This announcement is a separate document:
共同药业：2 会计师关于审核问询函的回复（豁免版）（2022年半年度财务数据更新）
Kyodo Pharmaceutical: 2 Accountants' Response to the Audit Inquiry Letter (Exempted Edition) (2022 Semi-Annual Financial Data Update)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.